泛素特异性蛋白酶5的生物学作用及其在肿瘤中的研究进展OA
The biological role of ubiquitin specific protease 5 and its research progress in tumor
泛素特异性蛋白酶5(USP5)作为去泛素化酶家族核心成员,通过水解未锚定多聚泛素链调控靶蛋白稳定性,在肿瘤发生、发展中发挥多重致癌作用.该文详细阐述了 USP5的结构与生物学功能.USP5是一种含835个氨基酸残基的多结构域酶,其具有锌指结构域(ZnF UBP)、UBP结构域及两个泛素相关结构域.USP5在维持蛋白质稳定性、参与肿瘤发生信号通路传导、发挥胞外生物学作用,以及调节肿瘤细胞周期、凋亡和代谢重编程等具有重要生物学功能.在肿瘤研究进展上,USP5在多种肿瘤中作为潜在的诊断标志物、治疗靶点和预后评估生物标志物展现出重要意义,虽然相关抑制剂及调节其表达或活性的策略在癌症治疗中取得一定成果,但仍需深入研究以克服局限性.未来可以开展大量临床研究,深入分析、整合分子机制,为肿瘤的诊断治疗和预后评估等提供新的视角和方向.
Ubiquitin-specific protease 5(USP5),also known as isopeptidase T(IsoT),functions as a key member of the deubiquitinating enzyme family.It regulates target protein stability by hydrolyzing unanchored polyubiquitin chains and plays multiple oncogenic roles in tumorigenesis and progression.This article elaborates on the structure and biological functions of USP5.USP5 is a multi-domain enzyme composed of 835 amino acid residues,featuring a zinc finger ubiquitin-specific protease domain(ZnF-UBP),a UBP domain,and two ubiquitin-associated domains.It plays crucial biological roles in maintaining protein stability,participating in tumor-related signaling pathways,exerting extracellular biological effects,and regulating tumor cell cycle,apoptosis,and metabolic reprogramming.In terms of advances in tumor research,USP5 has demonstrated significant potential as a diagnostic marker,therapeutic target,and prognostic biomarker in various cancers.Although certain achievements have been made in cancer therapy through related inhibitors and strategies that regulate USP5 expression or activity,further studies are still needed to overcome existing limitations.Future comprehensive clinical investigations and in-depth analysis and integration of molecular mechanisms will provide new perspectives and directions for tumor diagnosis,treatment,and prognosis evaluation.
李俊澍;詹辉;王海峰;王剑松
昆明医科大学第二附属医院泌尿外科,云南 昆明 650101昆明医科大学第二附属医院泌尿外科,云南 昆明 650101昆明医科大学第二附属医院泌尿外科,云南 昆明 650101昆明医科大学第二附属医院泌尿外科,云南 昆明 650101
医药卫生
泛素特异性蛋白酶5作用机制诊断标志物治疗靶点预后评估
ubiquitin-specific protease 5mechanism of actiondiagnostic markerstherapeutic targetsprognostic assessment
《中国现代医学杂志》 2026 (9)
57-64,8
国家自然科学基金(8206046482260609)
评论